MedTrace Logo

Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective

NCT02567604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2020-01-13

No results posted yet for this study

Summary

This study will explore experience of AMD caregivers in order to develop a core outcome set (COS) for age related macular degeneration (AMD) randomised controlled trials (RCTs) trying to capture what research outcomes are important from their perspective.

People 18 years of age and older who have been AMD caregivers for at least 6 months may be eligible for this study.

The aim is to conduct three focus groups lasting approximately one hour. The plan is to enrol 18-24 participants (6-8 participants per each of 3 focus groups).Two researchers will be involved in conducting the focus groups. A moderator will ensure fluid discussion, while the second investigator will be taking notes and audio-recording the discussion.

Conditions

  • Age Related Macular Degeneration

Interventions

BEHAVIORAL

Focus Groups

at least three focus groups lasting approximately one hour

Sponsors & Collaborators

  • Queen's University, Belfast

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02567604 on ClinicalTrials.gov